Skip to content
    MV

    Mubadala Ventures

    San Francisco, California, United StatesFounded 2017
    FintechBiotech & Life SciencesHealthcareMobility & TransportationLogistics & Supply ChainE-Commerce & Marketplace

    Mubadala Ventures focuses on early-stage and growth-stage technology companies globally, with specific strategies for Series A+ investments in U.S. technology and Series B+ in European technology, alongside investments in healthcare and biotech. Their strategy involves direct investments, a fund-of-funds approach, and leveraging Mubadala's global network to partner with founders in sectors like AI, cloud tech, and fintech, aiming for long-term, sustainable returns.

    Deal activity decreased year-over-year (4 deals in the last 12 months vs 7 prior). Average disclosed round size is $349.6M (across 68 rounds with reported amounts).

    Find people at Mubadala Ventures on Goldilocks AI

    Portfolio

    70

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    4

    Team

    FB

    Fatou Bintou Sagnang

    Partner

    AA

    Abdulla AlBanna

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    70 investments
    CompanyRoundAmountDate
    Juvena Therapeutics logoJuvena TherapeuticsSeries B$33.5MJan 2026
    Paradigm Health logoParadigm HealthSeries B$78MDec 2025
    Crusoe logoCrusoeSeries E$1.4BOct 2025
    Electra Therapeutics logoElectra TherapeuticsSeries C$183MOct 2025
    Crusoe logoCrusoeSeries D$600MDec 2024
    Huboo logoHubooGrowth$57MNov 2024
    Flink logoFlinkSeries D$150MSep 2024
    Outpace Bio logoOutpace BioSeries B$144MAug 2024
    Huboo logoHubooGrowth$57MJul 2024
    Storyblok logoStoryblokSeries C$80MJun 2024
    Arbol logoArbolSeries B$60MApr 2024
    Moove logoMooveSeries B$100MMar 2024
    Unlearn logoUnlearnSeries C$50MFeb 2024
    AAndalusia LabsSeries A$48MDec 2023
    tabby logotabbySeries D$200MOct 2023
    TreasurySpring logoTreasurySpringSeries B$29MJun 2023
    Chroma Medicine logoChroma MedicineSeries B$135MMar 2023
    Paradigm logoParadigmSeries A$203MJan 2023
    Precision Neuroscience Corporation logoPrecision Neuroscience CorporationSeries B$41MJan 2023
    tabby logotabbySeries B$58MJan 2023
    Vevo Therapeutics logoVevo TherapeuticsSeed$12MDec 2022
    UpStream Healthcare logoUpStream HealthcareSeries B$140MDec 2022
    Ramp logoRampSeries B$70MNov 2022
    Spotnana logoSpotnanaSeries B$75MJul 2022
    Auron Therapeutics logoAuron TherapeuticsSeries A$48MJul 2022
    Page 1 of 3

    Top Co-Investors

    Tiger Global Management9 shared
    General Catalyst6 shared
    Lux Capital5 shared
    DCVC5 shared
    Dragoneer Investment Group5 shared
    Steadview Capital5 shared
    ARCH Venture Partners4 shared
    GV (Google Ventures)4 shared
    Iconiq Capital4 shared
    M12 (Microsoft)4 shared
    SoftBank Vision Fund4 shared
    Northzone4 shared
    OMERS Ventures4 shared
    Sequoia Capital3 shared
    Silver Lake3 shared
    Valor Equity Partners3 shared
    Founders Fund3 shared
    Felicis Ventures3 shared
    White Star Capital3 shared
    Novator3 shared

    Last updated: 12 April 2026